Digital Mental Health Research Priorities, Revisited for the AI and Large Language Model Era
Clinical Snapshot
PICO Framework
| P — Population | Researchers, clinicians, policymakers, and stakeholders engaged in digital mental health; implicitly, patients and populations who use or may use digital mental health tools including those incorporating large language models (LLMs) |
| I — Intervention | Large language models (LLMs) and artificial intelligence (AI)-enabled digital mental health tools integrated into clinical care |
| C — Comparator | No formal comparator; the editorial contrasts the current LLM era against the 2023 JMIR Mental Health research priority framework |
| O — Outcomes | Research priorities for the field: equity, replicability, privacy, efficacy, engagement, safety, transparency, and ethical integration of AI/LLM tools into mental health care |
Bottom Line
This editorial from senior figures in digital mental health research updates the field's research priorities in response to the rapid proliferation of large language models and AI tools in mental health care. The authors reaffirm five core priorities — equity, replicability, privacy, efficacy, and engagement — while arguing that the urgency of applying these priorities has substantially increased as digital tools become more clinically consequential. The call to move beyond feasibility and novelty toward mechanistic understanding, population-specific benefit-harm analysis, and ethical integration is methodologically sound and clinically important. However, clinicians and policymakers should interpret this document for what it is: expert opinion at CEBM Level 5, without systematic evidence synthesis, formal consensus methodology, or primary data. The authorship group, while credentialed, is geographically narrow and does not demonstrably include patient or lived-experience perspectives. The priorities are broadly applicable to Australian practice, particularly regarding TGA regulation of AI-enabled SaMD, equity for underserved populations, and privacy obligations. Clinicians should treat these priorities as a useful research agenda rather than clinical guidance, and advocate for the rigorous, safety-attentive studies the authors themselves acknowledge are currently lacking.
Key Findings
Effect Size: Not applicable — no quantitative effect sizes reported
Primary Outcome: Articulation of updated research priorities for digital mental health in the LLM era, reaffirming and extending the 2023 JMIR Mental Health framework across five domains: equity, replicability, privacy, efficacy, and engagement
Nnt Or Sensitivity: Not applicable — editorial opinion; no diagnostic, therapeutic, or prognostic statistics reported
Confidence Interval: Not applicable — no statistical estimates provided
Clinical Application
The research priorities articulated are feasible to pursue within existing academic and health system infrastructure, though they require significant investment in interdisciplinary collaboration, regulatory engagement, and longitudinal study design. The call for transparency about technologies studied is immediately actionable for researchers and journal editors. In Australia, the TGA regulates Software as a Medical Device (SaMD) under the Therapeutic Goods (Medical Devices) Regulations 2002, and LLM-based mental health tools meeting the definition of SaMD require conformity assessment. The Australian Digital Health Agency's National Digital Health Strategy 2023–2028 and the RACGP's digital health position statements provide relevant governance frameworks. The priorities of equity and privacy align with Australia's obligations under the Privacy Act 1988 and the My Health Records Act 2012. PBS listing of digital therapeutics remains nascent, and the research gaps identified in this editorial — particularly around efficacy and safety — are directly relevant to future TGA and MSAC submissions. The emphasis on equity is particularly salient given persistent mental health access disparities in rural, remote, and First Nations communities in Australia. Mental health clinicians, digital health researchers, health service administrators, and policymakers considering the adoption or evaluation of LLM-enabled or AI-assisted digital mental health tools in clinical practice
Abstract
Digital mental health has become an established part of mental health care, but the rapid arrival of large language models and other artificial intelligence (AI) tools has refocused attention on the evidence needed to guide the field. This editorial updates the research priorities articulated by JMIR Mental Health in 2023, while reaffirming their emphasis on equity, replicability, privacy, efficacy, and engagement. While the importance of these priorities has not changed in recent years, the urgency with which they must now be applied has. As digital tools become more clinically consequential, research must move beyond demonstrating that a technology is feasible, usable, or novel. The field now needs studies that clarify how these tools work, for whom they are beneficial, under what conditions they may cause harm, and how they can be ethically integrated into care. We call for research that is transparent about the technologies being studied, grounded in meaningful clinical questions, attentive to safety, and designed to produce knowledge that remains useful as specific products and models change.
References
- 1.Birk, M. V., Kochhar, S., Myrick, K., Schueller, S. M., & Torous, J. (2026). Digital mental health research priorities, revisited for the AI and large language model era. JMIR Mental Health. https://doi.org/10.2196/104118
Related Research
Journal of psychiatric research
Systematic review of machine learning and deep learning models for EEG-based detection of depression.
2 Aug 2026
Sleep medicine reviews
Artificial intelligence in sleep medicine I: Diagnosis, treatment, care, and research
2 Aug 2026
International journal of yoga therapy
Randomized Controlled Trial on the Effect of Yoga on Anxiety Severity, Quality of Life, and Biomarkers in Individuals with Anxiety Disorder
31 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service